Discovery and preliminary characterization of novel tyrosine kinase inhibitors with to BTK

被引：0

作者：

Namdev, Nivedita D. ^{[1
]}

Cornell-Kennon, Susan ^{[1
]}

Yu, Yi ^{[1
]}

Hill, Jason ^{[1
]}

Bull, Cathy ^{[1
]}

Volak, Laurie ^{[1
]}

Wang, Jianqiang ^{[1
]}

Lowe, Deirdre ^{[1
]}

Gu, Xuibin ^{[1
]}

Koerner, Steffi ^{[1
]}

Moussa, Magdi ^{[1
]}

Vensel, David ^{[1
]}

Liu, Yanbin ^{[1
]}

Wu, Hui ^{[1
]}

Chen, Chang-Rung ^{[1
]}

Dransfield, Daniel T. ^{[1
]}

Ashwell, Mark A. ^{[1
]}

机构：

[1] ArQule Inc, Woburn, MA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期

关键词：

D O I：

10.1158/1535-7163.TARG-13-B270

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B270

引用

页数：1

共 50 条

[1] Discovery of novel selective spleen tyrosine kinase inhibitors
Northrup, Alan B.
Altman, Michael D.
Andresen, Brian M.
Anthony, Neville J.
Arrington, Kenneth L.
Bhat, Sathesh
Bienstock, Corey E.
Black, Cameron
Burch, Jason
Butcher, John W.
Childers, Kaleen Konrad
Cote, Bernard
Deschenes, Denis
di Francesco, Emilia
Donofrio, Anthony
Ducharme, Yves
Dupont-Gaudet, Kristina
Ellis, J. Michael
Fischer, Christian
Fournier, Jean-Francois
Friesen, Rick
Gauthier, Jacques Yves
Grimm, Jonathan B.
Guay, Daniel
Guerin, David J.
Haidle, Andrew M.
Jewell, James P.
Kattar, Solomon D.
Li, Chaomin
Lim, Jongwon
Lee, Sandra
Liu, Yuan
Machacek, Michelle R.
Maddess, Matthew L.
Miller, Thomas A.
O'Boyle, Brendan M.
Otte, Ryan D.
Peterson, Scott L.
Petrocchi, Alessia
Reutershan, Michael H.
Romeo, Eric T.
Robichaud, Joel S.
Schell, Adam J.
Siu, Tony
Smith, Graham F.
Spencer, Kerrie B.
Taoka, Brandon M.
Trotter, B. Wesley
Yang, Liping
Woo, Hyun Chong
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[2] Discovery of novel Bruton's tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold
Zhao, Xinge
Huang, Wei
Wang, Yazhou
Xin, Minhang
Jin, Qiu
Cai, Jianfeng
Tang, Feng
Zhao, Yong
Xiang, Hua
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (04) : 891 - 901
[3] STRATEGIES FOR THE DISCOVERY OF NOVEL TYROSINE KINASE INHIBITORS WITH ANTICANCER ACTIVITY
FRY, DW
KRAKER, AJ
CONNERS, RC
ELLIOTT, WL
NELSON, JM
SHOWALTER, HDH
LEOPOLD, WR
ANTI-CANCER DRUG DESIGN, 1994, 9 (04): : 331 - 351
[4] Design and synthesis of carbazole carboxamides as novel inhibitors of Bruton's tyrosine kinase (BTK)
Liu, Qingjie
Batt, Douglas G.
Baldwin, Kathy F.
Chang, ChiehYing
Lippy, Jonathan S.
Muckelbauer, Jodi K.
Strnad, Joann
Surti, Neha
Tebben, Andrew J.
Wang, Haiqing
Yang, Zheng
Fura, Aberra
Burke, James R.
Carter, Percy H.
Tino, Joseph A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
[5] Discovery of novel BTK inhibitors with carboxylic acids
Gao, Xiaolei
Wang, James
Liu, Jian
Guiadeen, Deodial
Krikorian, Arto
Boga, Sobhana Babu
Alhassan, Abdul-Basit
Selyutin, Oleg
Yu, Wensheng
Yu, Younong
Anand, Rajan
Liu, Shilan
Yang, Chundao
Wu, Hao
Cai, Jiaqiang
Cooper, Alan
Zhu, Hugh
Maloney, Kevin
Gao, Ying-Duo
Fischmann, Thierry O.
Presland, Jeremy
Mansueto, My
Xu, Zangwei
Leccese, Erica
Zhang-Hoover, Jie
Knemeyer, Ian
Garlisi, Charles G.
Bays, Nathan
Stivers, Peter
Brandish, Philip E.
Hicks, Alexandra
Kim, Ronald
Kozlowski, Joeseph A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1471 - 1477
[6] Discovery of novel dual Bruton's tyrosine kinase (BTK) and Janus kinase 3 (JAK3) inhibitors as a promising strategy for rheumatoid arthritis
Liang, Tingting
Cen, Lifang
Wang, Junjie
Cheng, Ming
Guo, Weibo
Wang, Wenjie
Yu, Chunqiu
Zhang, Haifeng
Wang, Yuan
Hao, Zhongyan
Jin, Jiaming
Wu, Yaoyao
Jiang, Teng
Zhu, Qihua
Xu, Yungen
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 96
[7] Discovery of thieno[3,2-c]pyridin-4-amines as novel Bruton's tyrosine kinase (BTK) inhibitors
Zhao, Xinge
Xin, Minhang
Wang, Yazhou
Huang, Wei
Jin, Qiu
Tang, Feng
Wu, Gang
Zhao, Yong
Xiang, Hua
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 6059 - 6068
[8] Bruton's Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
Burger, Jan A.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (01) : 44 - 49
[9] Bruton’s Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
Jan A. Burger
Current Hematologic Malignancy Reports, 2014, 9 : 44 - 49
[10] Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors
Tang, Chloe Pek Sang
McMullen, Julie
Tam, Constantine
LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1554 - 1564

← 1 2 3 4 5 →